Autophagic lipid metabolism sustains mTORC1 activity in TSC-deficient neural stem cells

Chenran Wang1, Michael A Haas2, Fuchun Yang2

  • 1Department of Cancer Biology, University of Cincinnati College of Medicine, Cincinnati, OH, USA. wang2cr@ucmail.uc.edu.

Nature Metabolism
|June 25, 2020
PubMed

Insights

Autophagy supports mTORC1 hyperactivation in Tuberous Sclerosis Complex (TSC) cells, driving disease pathology. Inhibiting autophagy reverses TSC defects and reduces tumor formation, offering a potential therapeutic strategy.

Area of Science:

  • Cell Biology
  • Neuroscience
  • Cancer Biology

Background:

  • mTORC1 signaling typically inhibits autophagy in cell cultures.
  • The in vivo impact of autophagy on mTORC1 signaling, particularly in neurological disorders, remains poorly understood.

Purpose of the Study:

  • To investigate the role of autophagy in supporting mTORC1 hyperactivation in Tuberous Sclerosis Complex (TSC) pathogenesis.
  • To explore the therapeutic potential of targeting autophagy in TSC.

Main Methods:

  • Utilized mouse models lacking Tsc1 and Fip200 in neural stem cells (NSCs).
  • Analyzed mTORC1 signaling, autophagy, and lipophagy under energy stress conditions.
  • Assessed the effects of inhibiting lipophagy and its downstream pathways on TSC-related phenotypes and tumorigenesis.

Main Results:

  • Autophagy is required to maintain mTORC1 hyperactivation in Tsc1-deficient NSCs, especially under energy stress.
  • Lipophagy provides lipids as an alternative energy source for oxidative phosphorylation (OXPHOS) in TSC-deficient cells.
  • Inhibition of lipophagy or its catabolic pathway ameliorated defective phenotypes and reduced tumorigenesis in vivo.

Conclusions:

  • Selective autophagy cooperates with energy availability to drive TSC pathogenesis.
  • Targeting lipophagy presents a potential therapeutic strategy for TSC patients.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Delivery Pathways to the Lysosome01:36

Delivery Pathways to the Lysosome

Eukaryotic cells use different mechanisms to eliminate toxic waste obsolete and worn-out substances. Lysosomes play a pivotal role in this, and hence, these substances are carried to the lysosome from other parts of the cell and extracellular space through different pathways. The most elaborately studied pathways to the lysosome are the endocytic pathways.
Endocytosis
In endocytosis, the cell membrane takes up macromolecules and particles from the surrounding medium. Clathrin-mediated...
8.6K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.1K